Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 3Unknown 2Terminated 1

Sponsor Class

INDUSTRY 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 2679Pancreatic Neoplasms 1470Colonic Neoplasms 1159Carcinoma, Hepatocellular 1142Stomach Neoplasms 1129Rectal Neoplasms 980Esophageal Neoplasms 728Neoplasms 559Liver Neoplasms 533Breast Neoplasms 473Neoplasm Metastasis 373Lung Neoplasms 325Carcinoma, Non-Small-Cell Lung 292Gastrointestinal Neoplasms 277Ovarian Neoplasms 258Prostatic Neoplasms 229Cholangiocarcinoma 221Head and Neck Neoplasms 180Gastrointestinal Stromal Tumors 176Melanoma 165Esophageal Squamous Cell Carcinoma 164Barrett Esophagus 156Uterine Cervical Neoplasms 151Biliary Tract Neoplasms 149Adenocarcinoma Of Esophagus 148Gallbladder Neoplasms 136Carcinoma, Renal Cell 134Urinary Bladder Neoplasms 132Sarcoma 131Anus Neoplasms 124

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Duodenal Ulcer × Gastrointestinal × Clear all
NCT02153398 2017-01-19

A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases

AstraZeneca

Phase 3 Completed
55 enrolled 31 charts
Gastrointestinal

Duodenal Ulcer, Esophagitis, Peptic, Stomach Ulcer, Zollinger-Ellison Syndrome

NCT01434485 2014-04-16

Nexium Capsules Clinical Experience Investigation

AstraZeneca

Completed
3,691 enrolled
Gastrointestinal

Non-Erosive Reflux Disease, Duodenal Ulcer, Esophagitis, Peptic, Stomach Ulcer, Zollinger-Ellison Syndrome

NCT01435525 2014-04-16

Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation

AstraZeneca

Completed
369 enrolled
Gastrointestinal

Duodenal Ulcer, Stomach Neoplasms, Stomach Ulcer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡